Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indo Amines Ltd
NSE:INDOAMIN
|
IN |
|
Gibus SpA
MIL:GBUS
|
IT |
|
S
|
Skarbiec Holding SA
WSE:SKH
|
PL |
Shandong Keyuan Pharmaceutical Co Ltd
Operating Expenses
Shandong Keyuan Pharmaceutical Co Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
|
Operating Expenses
-¥170m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥18.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥7.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Operating Expenses
-¥2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Expenses
-¥1.8B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Shandong Keyuan Pharmaceutical Co Ltd
Glance View
Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.
See Also
What is Shandong Keyuan Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-170m
CNY
Based on the financial report for Dec 31, 2025, Shandong Keyuan Pharmaceutical Co Ltd's Operating Expenses amounts to -170m CNY.
What is Shandong Keyuan Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-11%
Over the last year, the Operating Expenses growth was -17%. The average annual Operating Expenses growth rates for Shandong Keyuan Pharmaceutical Co Ltd have been -27% over the past three years , -11% over the past five years .
